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Abstract
Background: Dengue fever is one of the most dominant vector-borne diseases, putting approximately 3.9 billion
people at risk worldwide. While it is generally vector-borne, other routes of transmission such as needlestick injury
are possible. Laboratory workers can be exposed to dengue virus transcutaneously by needlestick injury. This is the
first case, to our knowledge, of dengue virus infection by needlestick injury in a laboratory environment. This paper
evaluates the risk and related health concerns of laboratory workers exposed to dengue virus.
Case presentation: We evaluated a 30-year-old female laboratory worker exposed to the dengue virus by
needlestick injury while conducting virus filtering. During admission, she showed symptoms of fever, nausea,
myalgia, and a characteristic maculopapular rash with elevated aspartate aminotransferase (AST) of 235 IU/L and
alanine aminotransferase (ALT) of 269 IU/L. She had been diagnosed by a positive nonstructural protein 1 (NS1)
antigen (Ag) rapid test one day prior to symptom onset along with positive immunoglobulin M (IgM) enzyme-
linked immunosorbent assay (ELISA) on the ninth day of symptom onset. Reverse transcription polymerase chain
reaction (RT-PCR), also conducted on the ninth day, was negative. After proper symptomatic treatment, she
recovered without any sequelae. As a result of thorough epidemiologic investigation, it was determined that she
had tried to recap the needle during the virus filtering procedure and a subsequent needlestick injury occurred.
Conclusions: In the context of health promotion of laboratory workers, we suggest that the laboratory biosafety
manual be revised and reinforced, and related prevention measures be implemented. Furthermore, health authorities
and health care providers in Korea should be fully informed of proper dengue fever management.
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Background
Dengue fever is a mosquito-borne tropical disease caused
by the dengue virus, found worldwide in tropical and sub-
tropical regions such as equatorial Africa, the Americas,
and Southeast Asia. The World Health Organization
(WHO) reports that about 3.9 billion people in 128 coun-
tries worldwide were in danger of dengue fever infection
in 2015. It is reported that 390 million people are infected
annually, and about 96 million people among them have
an apparent infection [1]. In South Korea, dengue fever is
a legally designated infectious disease. Its incidence is in-
creasing, with 149 cases in 2012, 252 cases in 2013, and
165 cases in 2014. As of 2014, it is estimated that most
dengue infections were brought in from overseas [2].
Dengue fever is usually transmitted by a few species of
mosquito within the genus Aedes, principally A. aegypti.
Aedes species that transmit the disease also include A.
albopictus, A. polynesiensis, and A. scutellaris [1, 3]. In
general, dengue fever is known as a mosquito-borne infec-
tious disease, but it can be transmitted from vertical infec-
tion, blood transfusion, organ transplants, and needlestick
injuries [4]. Among cases of needlestick injury, health care
providers have rarely been reported to have been infected
by a syringe needle used for a patient that has dengue
virus [4–7]. Biosafety laboratory workers are exposed to
diverse pathogenic organisms in the course of their
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professional work. Exposure routes for them differ accord-
ing to their job duties and the characteristics of the patho-
gens they encounter; exposure can be through the
respiratory tract, mucous membranes, oral intake, or per-
cutaneous methods. Global laboratory-acquired infections
include those from Brucella, Yersinia, and buffalopox,
among others [8–11]. A case of dengue fever-related la-
boratory infection was reported in Australia. In a labora-
tory, where studies that involved infecting mosquitoes
with the dengue virus and disease spread were conducted,
one researcher was reported to be infected by the dengue
virus that was studied in that laboratory. The exposure
route, however, was not clear [12]. This is the first report
of an actual non-mosquito vector infection case in South
Korea. The authors describe here the first reported dengue
fever infection case caused by needlestick injury in a
laboratory environment rather than that in a clinical envir-
onment, along with a review of the related literature.
Case presentation
Patient
Female, 30 years old.
Chief complaint
Chills, febrile sensation, muscle pain.
Past medical history or family-related medical history
There was nothing significant to report. No one in her
family had ever had dengue fever.
Social history
None of her coworkers showed similar symptoms or
were diagnosed with dengue fever. In the region where
she lives, there was no report of any dengue fever case.
She had not been recently bitten by any mosquito
because it was winter at the time.
History of overseas travel
A year before she was injured by the syringe needle, she
had visited Hong Kong for a short period. She had no
other travel history.
Exposure investigation
The laboratory where she worked was a biosafety level 2
research facility. When she was injured by the syringe
needle, she was in charge of infecting cultured mosquito
cells with dengue virus type 2 (DENV-2). During that
procedure, she transferred dengue virus solution in a
50 mL conical tube (hereafter referred to as “the tube”)
into a 10 mL syringe (hereafter referred to as “the syr-
inge”). Then, she connected the syringe to a disposable
filter in order to filter the virus solution (Fig. 1). While
she was suctioning the virus solution with the syringe,
she removed the needle attached to the syringe. At that
moment, the needle cap was not stripped away. How-
ever, as she repeated that procedure, the amount of the
virus solution contained in the tube decreased. She,
therefore, reattached the needle to the syringe and
stripped away the cap in order to suction the rest of the
virus solution. When she tried to recap the needle to
remove it, she was injured (Fig. 2).
Present medical history
The patient washed the wound in running water for
10 min according to laboratory biosafety accident coun-
termeasures and first aid guidelines immediately after
she was wounded. She, however, could not disinfect the
wound because the necessary materials were not on
hand. She went to a nearby hospital, got the wound
disinfected, and went home. She kept working in that
laboratory unit after the accident. She conducted daily
self-tests using the SD BIOLINE Dengue NS1 Ag Rapid
Test (Standard Diagnostics Inc., Yongin, South Korea),
which is a rapid diagnostic test for dengue virus non-
structural protein 1 (NS1) antigen (Ag). Ten days after
she was wounded, a positive test result was confirmed
(Fig. 3). Symptoms had started one day before the posi-
tive reaction was confirmed. Muscle pains began first.
Then, vomiting, chills, and a febrile sensation followed.
Two days later, a rash started around both knees (Fig. 4).
As symptoms appeared and a positive reaction was con-
firmed from a diagnostic kit, she went to a university
hospital in the city of Gwangju on the third day of the
symptoms. However, she did not receive any special
Fig. 1 Dengue virus solution filtering procedure. a Aspiration. b Filtering
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examination or treatment. On the next day, the symp-
toms continued, and she was hospitalized in a commu-
nity hospital near her home for symptomatic treatment.
Physical examination
When she was admitted to the hospital, the patient’s blood
pressure, pulse, and respiration rate were all within a nor-
mal range. Her body temperature measured in the axillary
region was 37.3 C, indicating a mild fever. There was a
rash around both knees, but physical examination re-
vealed no other abnormalities such as edema or ascites.
Laboratory examination
The patient’s blood test results when admitted were as
follows: complete blood cell count results showed leuko-
cytes of 3,390/mm3, hemoglobin of 13.3 g/dL, platelets
of 300,000/mm3, and hematocrit of 41.0 %, showing
slight leukopenia. The blood chemistry examination
showed aspartate aminotransferase (AST) of 33 IU/L,
alanine aminotransferase (ALT) of 26 IU/L, total protein
of 7.7 g/dL, and albumin of 4.3 g/dL, which were within
a normal range. Urine examination results were normal.
On her sixth day of hospitalization, her blood sample
was sent to the Korea National Institutes of Health
(KNIH) for confirmatory tests. Immunoglobulin M
(IgM) was measured twice using the DENV Detect™ IgM
Capture enzyme-linked immunosorbent assay (ELISA)
(InBios International, Inc., Seattle, WA, USA) and Pan-
bio® Dengue IgM Capture ELISA (Panbio Diagnostics,
Brisbane, Queensland, Australia) once each. Both tests
were positive. However, reverse transcription polymerase
chain reaction (RT-PCR) was negative (Table 1) [13, 14].
Fig. 2 Simulated usage of the needle during the worker’s filtering procedure at the time of injury. a Connecting the syringe to the needle. b Recapping
the needle after use. c Needlestick injury
Fig. 3 The test results of the NS1 Ag Rapid Test. a On the 7th day after the needlestick injury. b On the 10th day after the needlestick injury
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Clinical progress
During hospitalization, she complained of symptoms
such as muscle pains, chills, mild fever, nausea, vomit-
ing, and skin rashes accompanied by itchiness. In
order to relieve her symptoms, she was treated with
acetaminophen, antihistamines, and so on. On the
third day of hospitalization, in spite of the ongoing
treatments, the muscle pain expanded to her entire
body, and the rash kept spreading to other parts of
her body. However, on the fifth day of hospitalization,
her major symptoms disappeared, except the rash. The
rash continuously expanded to her entire body, in-
cluding her arms, legs, and face. Then, on the seventh
day of hospitalization, the rash began to improve.
Blood tests on the third day of hospitalization showed
leukocytes of 2,410/mm3, showing that leukopenia had
worsened. AST and ALT increased to 66 IU/L and
48 IU/L, respectively. On the sixth day of hospitalization,
leukocytes were 6,390/mm3, showing no leukopenia.
However, AST was 235 IU/L and ALT was 269 IU/L,
both increasing further. Then she was treated with hepa-
totonics. On the eighth day of hospitalization, when she
was discharged, AST and ALT decreased to 46 IU/L and
145 IU/L, respectively (Table 2). She had neither residual
symptoms nor blood parameter abnormalities when she
underwent follow-up two weeks later.
Discussion
Exposure to human immunodeficiency virus (HIV),
hepatitis B virus (HBV), and hepatitis C virus (HCV) via
occupational percutaneous injuries is common globally as
well as in South Korea [15, 16]. On the other hand, less
than ten reported cases of dengue fever via needlestick
injuries have been reported worldwide. Most notably, not
a single case like the one reported here, where a laboratory
worker experienced the needlestick injury during work,
has been reported previously [4]. The exposure investiga-
tion revealed that there were no events of exposure to
dengue virus such as the vector-borne method by mosqui-
toes or blood-mediated exposure other than the needle-
stick injury.
This case has some marked characteristics that differ
from those of other reported cases of dengue fever infec-
tion by needlestick injury. First, all other reported den-
gue fever needlestick injury cases have occurred within
clinical environments in which dengue fever patients
were being treated. However, in this case, a laboratory
worker was injured while working in a well-controlled
laboratory environment dealing with dengue virus. Sec-
ond, the laboratory where the infected worker worked
was equipped with a rapid diagnosis kit. The worker,
therefore, continued to self-test even while symptoms
had not yet occurred, and was able to diagnose herself
Fig. 4 Maculopapular rash of the patient on the third day of admission
Table 1 The results of the diagnostic tests
Tests (Day 17)a Result
DENV Detect™ IgM Capture ELISAb +(ISR 6.5)
Panbio® Dengue IgM Capture ELISAc +(Panbio Units 95.7)
RT-PCR -
aTests were performed using blood samples collected on the sixth day of
hospitalization, which was the seventeenth day after the needlestick injury
(Day 0)
bInBios International, Inc., USA. Immune status ratio (ISR) values ≥2.84 are
considered positive
cPanbio Diagnostics, Australia. Panbio Unit values >11.0 are
considered positive
Table 2 Progress of the laboratory test parameters during
hospitalization
Day 12a Progress
Day 14 Day 17 Day 19b
White blood cells (/mm3) 3,390 2,410 6,390 6,720
Eosinophils (%) 4.4 3.7 0.5 2.1
Hematocrit (%) 41.0 35.0 37.0 37.7
Platelets (/mm3) 300,000 194,000 243,000 311,000
AST (IU/L) 33 66 235 46
ALT (IU/L) 26 48 269 145
Total protein (g/dL) 7.7 6.2 7.0 6.7
Albumin (g/dL) 4.3 3.5 3.8 3.6
Total bilirubin (mg/dL) - 0.5 0.4 -
Direct bilirubin (mg/dL) - 0.2 - -
aAt the time of admission, which was the 12th day after the needlestick injury
(Day 0)
bAt the time of discharge
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quickly. This is a point worth noting, since it enabled sec-
ondary prevention. Thirdly, in this case, proper post-
management between the worker and the laboratory was
made, so the disease treatment began quickly. The worker,
therefore, was able to return to work quickly. She was
immediately reassigned to a new task to prevent recur-
rence. This case, hence, is considered a model case from
the standpoints of primary and tertiary prevention.
Here, we will discuss a few issues in three major sec-
tions: laboratory biosafety; clinical and epidemiological
characteristics of dengue fever infection and job fitness;
and general preparedness for dengue fever diagnosis and
treatment.
Laboratory biosafety
Unlike in clinical environments, where procedures are
not always done in an orderly manner, we believe that
laboratory workers’ exposure to pathogens can be effect-
ively controlled through preventive measures such as
having a strict biosafety laboratory facility standard, op-
eration adjustments, substitution of experimental tools,
safety devices and equipment, and education to prevent
infections by pathogens handled in the laboratory. We,
therefore, think that it will be meaningful to find prac-
tices in need of improvement among precautionary
measures for biosafety laboratory workers by considering
the exposure route in this case.
Biosafety laboratories must run their facilities and sup-
ply materials according to a strict management standard,
and have a safety guide. The procedure that caused the
needlestick injury to the worker was as follows: she
transferred dengue virus solution from a 50 mL tube
into a 10 mL syringe. Then, she connected that syringe
with a disposable filter in order to filter the virus solu-
tion. She used the syringe by attaching a needle. At the
moment she tried to recap the needle, she was injured.
There are a few problems to be addressed in this pro-
cedure. According to our investigation, when transfer-
ring the virus solution to the disposable filter, one could
use either a pipette or syringe. When there was a small
quantity of virus solution, she used a syringe. At this
point, there would have been no problem if she had used
the syringe without the needle. However, by attaching
the needle to the syringe, she made it possible for the in-
jury to occur. The patient, herself, actually was aware of
the risk of a wound while using the needle. However,
she thought that the tip of the syringe was too thick to
suck in the small amount of the virus solution left in the
tube. This is the reason why she used the needle. What’s
worse, she recapped the needle after using the syringe.
This is the most common cause of needlestick injuries
in general. When considering the series of steps during
which this accident occurred, we were able to find struc-
tural causes other than the patient’s carelessness.
In examining guidelines for safety management of bio-
safety laboratories, there is a local guideline published by
the Korea Centers for Disease Control and Prevention
(KCDC) in South Korea. There is also a global manual
for laboratory biosafety published by the WHO. In the
local guideline, there are restrictions on using syringes,
such as limiting the use of sharp material like syringes
and replacing them with plastic material if possible [17].
The laboratory biosafety manual published by the WHO,
meanwhile, is more specific as follows: Minimize use of
syringes and needles. Never recap the needle, and dis-
card it in a separate container for needles only [18]. We
think that the manual by the WHO provides more de-
tailed guidelines about using needles than the Korean
guidelines. However, we believe that changing expressions
in the WHO’s manual; for example, change “minimize
using syringes and needles” into “syringes and needles
must not be used in a situation where their use is not
directly indicated” would be more appropriate in order to
remove any potential risk of needlestick injuries. Along
with this point, evaluating job fitness about return to work
and task allocation for laboratory workers who have been
infected must be included in the next revision of the
guidelines.
Furthermore, managing and supervising whether these
guidelines are properly obeyed or not is also crucial. In
this case, the patient was in a situation where she had to
use the needle, but there was no separate discarding
container for the used needle in the laboratory. There-
fore, she had to recap the needle. Furthermore, she
washed her wound in running water according to the
laboratory’s manual of countermeasures for emergency
incidents, but there was no first aid kit that could disin-
fect the wound in the laboratory. In this case, the fact
that she could not disinfect the wound did not greatly
affect the disease progression, which was fortunate. We,
however, think that taking appropriate action at the be-
ginning of the infection incident is essential to prevent
any secondary infection of contaminated wounds. It will,
therefore, be vital to supervise whether safety equipment
is managed according to safety guidelines.
Dengue fever and job fitness of laboratory workers
We also need to address the health care of laboratory
workers and dengue fever infection in more depth. Den-
gue virus is a small single-stranded RNA virus, and there
are four distinct dengue virus serotypes, from type 1 to
type 4. Concurrent or secondary infections of different se-
rotypes are possible. When infected, patients are classified
into either non-severe dengue or severe dengue. Non-
severe dengue is divided again into two subgroups: those
with warning signs and those without warning signs.
Warning signs are as follows: abdominal pain or tender-
ness; persistent vomiting; clinical fluid accumulation;
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mucosal bleeding; lethargy, restlessness; liver enlargement
by more than 2 cm; and an increase in hematocrit concur-
rent with a rapid decrease in platelet count. Those with
warning signs are prone to severe dengue. Criteria for
probable dengue fever include fever and two of the follow-
ing: nausea, vomiting; rash; aches and pains; positive tour-
niquet test; leucopenia; or any warning signs. Severe
dengue is life-threatening and comprises severe plasma
leakage leading to shock, severe bleeding, and severe
organ involvement [3]. High body mass index (BMI), be-
ing a child or female, chronic diseases like asthma or
diabetes, high viral load, and concurrent or secondary in-
fection with other serotypes of dengue virus are associated
with a greater risk of a severe clinical course [19–28].
Among these risk factors, we will discuss concurrent or
secondary dengue virus infection at work and possible
high viral load during infection by a needlestick injury.
In this case, there was a needlestick injury, and it then
took 10 days until a positive result appeared on the
Dengue NS1 Ag Rapid Test. The patient kept working
in the same unit using the same virus filtering method
described above until the dengue fever symptoms ap-
peared. The operation in the unit she worked for dealt
with all four dengue virus serotypes. Therefore, she was
exposed to an environment where she could have been
infected with some or all of the four dengue virus
serotypes during the filtering operations. It has been
suggested that if the patient becomes infected by several
dengue serotypes concurrently, the case may display a
more severe clinical course, though this remains under
question [19–23]. Even if the greater potential risk of
multiple serotype infection is controversial, we believe it
is appropriate to isolate workers who have experienced
needlestick injuries from all work handling the dengue
virus until a definite diagnosis is made in order to pro-
tect them. Moreover, if a concurrent infection from
other pathogens such as hepatitis C or malaria occurs, it
can worsen the clinical course [29–32]. Thus, allocating
workers infected with dengue virus should be done with
careful consideration.
It is also important that the potential for secondary
dengue virus infection be taken into consideration in
terms of the worker’s future job compatibility. If there is
a secondary infection by another dengue virus serotype,
the risk of a severe case of dengue fever increases. Spe-
cifically, when a person who was infected with dengue
virus type 1 (DENV-1) is infected secondarily with
DENV-2 or dengue virus type 3 (DENV-3), or when a
person who was infected with DENV-3 is infected sec-
ondarily with DENV-2, it has been reported that the risk
of severe dengue fever increases [24, 33]. Further re-
search must be undertaken in order to elucidate the
effects of related risk factors since there have been few
studies on factors of secondary dengue virus infection
that may increase severe dengue fever, such as combina-
tions of serotypes and gaps between primary and sec-
ondary infections. In this case, the laboratory reallocated
the patient to another unit that did not handle the den-
gue virus at all when the patient finished dengue fever
treatment to prevent secondary dengue virus infection.
Essential information, however, was not provided by the
health care providers during the treatment or right after
its completion. It was fortunate that, in this case, those
at the laboratory had sufficient knowledge about dengue
fever. A medical evaluation must be made jointly among
medical experts, the laboratory and the laboratory workers
prior to the worker’s return to work. Furthermore, in non-
occupational environments such as traveling to a dengue
fever-endemic region, the patients should be aware of and
avoid secondary dengue virus infections.
It is known that, in general, about 10 to 20 dengue
virus copies are needed for a person to be infected with
dengue virus by a mosquito bite. In case of a needlestick
injury, however, more virus copies are needed than in
the above natural infection course. This number is not
precisely known, but the number for HIV infection by
needlestick injury is approximately 500. It is, therefore,
expected that a similar number of dengue virus copies
may cause infection [4]. As discussed above, the number
of virus copies required for the needlestick injury would
be more than for a mosquito bite infection. A relation-
ship between the number of dengue virus copies at the
moment of infection and viral load during the infection
has not been clearly determined. Thus, further research
is required on whether the viral load during the infection
by needlestick injury is higher than that via mosquito
bite infection, given that more virus copies are needed
for the needlestick injury-mediated infection.
General preparedness for clinical dengue management in
South Korea in question
Besides the matters discussed above, the general pre-
paredness of medical professionals in South Korea for
dengue fever should also be addressed. On the third day
of symptom onset, the patient went to a university hos-
pital for treatment. The health care providers of the
hospital just had the patient return home based on an
observation of the relatively mild symptoms of the pa-
tient at that moment, without performing essential tests
such as physical examinations or blood tests. They
should have evaluated the patient’s condition clinically
and taken initial actions to observe the clinical course
because dengue fever may transform into a fatal case of
severe dengue fever without showing any special symp-
toms at the beginning [3]. On the next day, the patient
was hospitalized near her home. Routine blood tests
including a complete blood cell count were conducted,
but no tests were done for differential diagnosis. Plus,
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laboratory tests for definite diagnosis of the dengue fever
were only performed on the sixth day of hospitalization
(the ninth day of symptom onset).
Laboratory tests to diagnose dengue fever include
virus isolation using cell culture, nucleic acid detection
using RT-PCR, NS1 Ag detection, and serological
methods such as IgM or immunoglobulin G (IgG) detec-
tion. Viral antigen and nucleic acid methods of detecting
the virus can be used when a clinical specimen has been
collected during the viremic period, which is one to five
days after the symptom onset. After this period, sero-
logical methods can be used. Direct virus detection is
more reliable than the indirect serological method [3].
To confirm a diagnosis of dengue fever according to the
Dengue Control (DENCO) study, the following condi-
tions must be met: PCR is positive; it is positive in virus
culture; IgM seroconversion is confirmed in paired
serum; IgG seroconversion is confirmed in paired serum;
and an IgG titer increase of at least 4-fold is confirmed.
Moreover, the probability of infection by dengue fever is
highly suggested when IgM is positive in one serum test
or the titer of IgG is above 1:1280 [3, 34].
In this case, the serum test was conducted once using
a specimen collected on the ninth day of symptom onset
and was sent to the testing facility to make the diagnosis,
which was too late for direct diagnostic methods. Conse-
quently, test results for RT-PCR were negative and
results for IgM were positive. This was not sufficient to
diagnose the case as dengue fever with certainty accord-
ing to the criteria of the DENCO study. However, in this
case, the patient conducted self-tests and kept the result
of the Dengue NS1 Ag Rapid Test, which showed a posi-
tive reaction, and this helped the patient to be diagnosed
with dengue fever. The SD BIOLINE Dengue NS1 Ag
Rapid Test (Standard Diagnostics Inc., Yongin, South
Korea) used by the patient showed 72.4 % sensitivity and
100 % specificity in a study that compared the efficacy of
several dengue NS1 Ag rapid tests [35]. Moreover,
dengue fever can be suspected clinically aside from la-
boratory methods of diagnosis. In this case, the patient
showed clinical symptoms that fit dengue fever (fever
with nausea, vomiting, muscle pains, characteristic
maculopapular rash, and leukopenia) along with the
serological test and Dengue NS1 Ag Rapid Test, increas-
ing the reliability of the dengue fever diagnosis [24].
The implications of this case for the dengue fever
diagnosis process are twofold. First, the reliability of
dengue fever diagnosis by domestic health care providers
in Korea can be low due to insufficient experience and
preparedness. Based on how this case was handled, the
health care providers seem to have lacked knowledge of
appropriate dengue fever treatment or diagnosis guide-
lines. Therefore, related institutions and health author-
ities should provide continuing education and training
programs to prepare for an increase in dengue fever
patients in the future. Second, the laboratory worker
handling the dengue virus used the Dengue NS1 Ag
Rapid Test, and this enabled rapid diagnosis and treat-
ment. Although perfect countermeasures that fit with
the guidelines were not performed during the diagnosis
and treatment process, the patient was motivated to
keep visiting medical institutions, allowing for timely
diagnosis and treatment, which is very important. When
an infection incident happens in a laboratory handling
the dengue virus, arranging for a rapid test kit may help
protect laboratory workers’ health by enabling timely
diagnosis and treatment.
Conclusion
This case concerned a non-mosquito vector dengue
fever infection, where the laboratory worker was infected
from a needlestick injury in a laboratory environment.
We believe that proper prevention measures, such as
revising the guidelines and considering job fitness, must
be implemented to promote and protect laboratory
workers’ health. Dengue fever is not endemic in South
Korea, and general preparedness is relatively low. How-
ever, we expect that more patients in countries like South
Korea without endemic dengue fever will suffer from
dengue fever owing to increasing international travel and
global climate change. Therefore, health authorities and
health care providers in such countries should be well
aware of appropriate dengue fever management.
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